Optimal ferritin threshold to diagnose IEC-HS following CAR T-cell therapy in R/R myeloma
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-01-28
Просмотров: 57
Описание:
Lekha Mikkilineni, MD, National Institutes of Health, Bethesda, MD, presents a study investigating the optimal ferritin threshold to diagnose immune effector cell-associated hemophagocytic syndrome (IEC-HS) following CAR T-cell therapy in relapsed/refractory (R/R) multiple myeloma. Dr Mikkilineni highlights that a ferritin level of 7,500 nanograms per milliliter may serve as a simple and accessible biomarker for earlier identification of IEC-HS in patients treated with ciltacabtagene autoleucel (cilta-cel) or idecabtagene vicleucel (ide-cel). However, validation of this finding is needed. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: